Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
Darya-Varia Laboratoria Tbk
DVLA
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
167
ROE
12,49%
ROA
7,19%
Book Value
1.339
Net Income
93,72 M
Total Sales
1,21 T
Total Assets
2,61 T
DER
0.74x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
4,04%
Tentang Perusahaan
PT Darya-Varia Laboratoria Tbk (the Company) was established, under notarial deed No. 5 dated February 5, 1976 as amended byu deed No. 148 dated April 30, 1976 made before notary public Abdul Latief, S.H. The Company is specialized in the production of soft gelatin-based capsule.
Produk & Lini Bisnis
The Company is engaged in the manufacture, trade and distribution of pharmaceuticals and related chemicals and health care products. Currently, the Company is active in the manufacture, trade and services of pharmaceutical products.
Dewan Direksi
DM
dr.Ian Martin Wibawa Kloer
President Director
AC
Angelito Celso Corsame Racho, Jr.
Director
YE
Yustina Endang Setyowati
Director
DT
Dennis Tee Co
Director
CP
Celso Paz Lim
Director
Dewan Komisaris
CA
Clinton Andrew Campos Hess
President Commissioner
EA
Eric Albert Lim Gotuaco
Vice President Commissioner
SK
Sonny Kalona
Independent Commissioner
SA
Sancoyo Antarikso
Independent Commissioner
MH
Marlia Hayati Goestam
Independent Commissioner
MJ
Mariano John Lim Tan, Jr
Commissioner
Anak Usaha & Afiliasi
| Nama | Domisili | % |
|---|---|---|
| % |
Trend Keuangan (5 periode terakhir)
— hover bar untuk detail
Total Sales
Net Income (+)
Net Income (-)
2025 Q2
EPS 217
ROE 16,27%
2025 Q3
EPS 196
ROE 14,27%
2025 Q4
EPS 146
ROE 11,08%
2026 Q1
EPS 198
ROE 14,42%
2026 Q2
EPS 167
ROE 12,49%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
| Periode | Total Sales | Net Income | Total Assets | Total Equity | EPS | ROE | DER |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 1,21 T | 93,72 M | 2,61 T | 1,50 T | 167 | 12,49% | 0.74x |
| 2026 Q1 | 594,80 M | 55,31 M | 2,52 T | 1,53 T | 198 | 14,42% | 0.64x |
| 2025 Q4 | 2,23 T | 163,95 M | 2,35 T | 1,48 T | 146 | 11,08% | 0.59x |
| 2025 Q3 | 1,63 T | 164,33 M | 2,39 T | 1,53 T | 196 | 14,27% | 0.56x |
| 2025 Q2 | 1,09 T | 121,44 M | 2,40 T | 1,49 T | 217 | 16,27% | 0.61x |
History Harga Penutupan & Book Value
| Tahun | Qrt | Close Price (Rp) | Book Value (Rp) | ROA |
|---|---|---|---|---|
| 2026 | 2 | 1.525 | 1.339 | 7,19% |
| 2026 | 1 | 1.605 | 1.370 | 8,79% |
| 2025 | 4 | 1.650 | 1.321 | 6,98% |
| 2025 | 3 | 1.625 | 1.371 | 9,18% |
| 2025 | 2 | 1.610 | 1.333 | 10,13% |
Data diperbarui pada: 2026-05-12 10:20:42